Can early βhCG change and baseline progesterone level predict treatment outcome in patients receiving single dose Methotrexate protocol for tubal ectopic pregnancy?
- 7 Downloads
We aimed to assess the prognostic significance of early βhCG change and baseline progesterone level on treatment outcome among women receiving single dose Methotrexate protocol for tubal ectopic pregnancy (EP).
Material and methods
Retrospective study involving all consecutive patients diagnosed with EP and receiving Methotrexate therapy form January 2015 to December 2016. Patients were stratified into 2 groups according to treatment outcome: success group (n = 66) involved women who displayed complete resolution of serum βhCG levels following a single course of Methotrexate; failure group (n = 55) included patients who required repeated Methotrexate administration and/or surgical management. Predictive performances of baseline progesterone and ratio“βhCG level on day 4/ βhCG level on day 1″ (d4/d1) on treatment outcome were assessed using Receiving Operating Characteristics curves.
The ratio d4/d1 displayed good performances in predicting treatment outcome (AUC = 0.826). A ratio ≤ 0.7 was associated with a success rate of 94% after 1 course of Methotrexate and 100% after 2 courses. In contrast, a ratio >1.7 was associated with a failure rate of 100%. Conversely, baseline progesterone showed poor performances (AUC = 0.611).
Patients with extreme βhCG changes (n = 33) on day 4 might benefit from a more personalized approach: simplified monitoring in those with a decline ≥30%, anticipated second course of treatment in those with an increase > 70%.
KeywordsTubal ectopic pregnancy Methotrexate Early βhCG change Baseline progesterone Prognosis
JB manuscript writing, statistical analysis. PG data collection, project development. CC data collection, project development. AY data collection. MB data collection, clinical management. OP manuscript reviewing. CV manuscript reviewing. CV manuscript reviewing. EC data collection, project development. FV manuscript writing, statistical analysis, project development.
Compliance with ethical standards
Conflict of interest
All authors declare no conflict of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
- 2.Stovall TG, Ling FW, Gray LA (1991) Single-dose methotrexate for treatment of ectopic pregnancy. Obstet Gynecol. 77(5):754–757Google Scholar
- 5.Gervaise A (2003) Management of non-surgical treatment of ectopic pregnancy. J Gynecol Obstet Biol Reprod 32(7 Suppl):S64–74Google Scholar
- 8.Coste J, Bouyer J, Job-Spira N (1996) Epidemiology of ectopic pregnancy: incidence and risk factors. Contracept Fertil Sex. 24(2):135–139Google Scholar